Jitendra Wadhane's most recent trade in Pyxis Oncology Inc was a trade of 263,782 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pyxis Oncology Inc | Jitendra Wadhane | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 263,782 | 263,782 | - | - | Stock Option (Right to Buy) | |
| Pyxis Oncology Inc | Jitendra Wadhane | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Pyxis Oncology Inc | Jitendra Wadhane | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2024 | 131,484 | 398,421 | - | 0 | Common Stock | |
| Pyxis Oncology Inc | Jitendra Wadhane | Chief Accounting Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Mar 2023 | 157,257 | 0 | - | - | Stock Option (Right to buy) | |
| Pyxis Oncology Inc | Jitendra Wadhane | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 157,257 | 157,257 | - | - | Stock Option (Right to buy) | |
| Pyxis Oncology Inc | Jitendra Wadhane | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 45,000 | 88,648 | - | 0 | Common Stock | |
| Pyxis Oncology Inc | Jitendra Wadhane | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 29,393 | 118,041 | - | 0 | Common Stock |